Konark Herbals And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.50 Cr
as on 16-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 16-11-2024
- Revenue 11.69%
(FY 2023)
- Profit -35.17%
(FY 2023)
- Ebitda -30.14%
(FY 2023)
- Net Worth 53.20%
(FY 2023)
- Total Assets 25.05%
(FY 2023)
About Konark Herbals And Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹15.00 Cr.
Rakesh Sajjan and Vedant Gupta serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC361443
- Company No.
361443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Konark Herbals And Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Sajjan  | Director | 02-Jun-2021 | Current |
| Vedant Gupta | Director | 02-Jun-2021 | Current |
Financial Performance of Konark Herbals And Healthcare.
Konark Herbals And Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.69% increase. The company also saw a substantial fall in profitability, with a 35.17% decrease in profit. The company's net worth Soared by an impressive increase of 53.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Konark Herbals And Healthcare?
In 2023, Konark Herbals And Healthcare had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kpf Lifesciences Private LimitedActive 45 years 7 monthsRakesh Sajjan and Vedant Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Oct 2023 | ₹15.00 Cr | Open |
How Many Employees Work at Konark Herbals And Healthcare?
Konark Herbals And Healthcare has a workforce of 301 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Konark Herbals And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Konark Herbals And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
